Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

2.6 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

Stryker has received 51.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Stryker and other stocks. Vote “Outperform” if you believe SYK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SYK will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.0 Company Ownership

In the past three months, Stryker insiders have sold 39,691.96% more of their company's stock than they have bought. Specifically, they have bought $9,695.00 in company stock and sold $3,857,831.00 in company stock.

Miscellaneous

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYK stock has increased by 17.9% and is now trading at $207.03. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Stryker?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

When is Stryker's next earnings date?

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its quarterly earnings data on Thursday, April, 30th. The medical technology company reported $1.84 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.69 by $0.15. The medical technology company earned $3.59 billion during the quarter, compared to the consensus estimate of $3.45 billion. Stryker had a net margin of 14.47% and a return on equity of 24.90%. The firm's quarterly revenue was up 2.0% compared to the same quarter last year. During the same period last year, the business posted $1.88 earnings per share. View Stryker's earnings history.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Tuesday, May 5th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.575 per share on Friday, July 31st. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date of this dividend is Monday, June 29th. View Stryker's dividend history.

What price target have analysts set for SYK?

27 Wall Street analysts have issued 12-month price objectives for Stryker's stock. Their forecasts range from $150.00 to $248.00. On average, they anticipate Stryker's share price to reach $215.20 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View analysts' price targets for Stryker.

Has Stryker been receiving favorable news coverage?

News headlines about SYK stock have trended somewhat negative on Sunday, according to InfoTrie. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stryker earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutStryker.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Mackenzie Financial Corp, Nuveen Asset Management LLC, JPMorgan Chase & Co., State of Michigan Retirement System, Greenleaf Trust, UBS Group AG, and Canada Pension Plan Investment Board. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $207.03.

How big of a company is Stryker?

Stryker has a market capitalization of $77.60 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.